A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BACKGROUND: Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies. We set out to determine whether a multivariable model including four kallikrein forms (total, free, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vickers, Andrew J, Cronin, Angel M, Aus, Gunnar, Pihl, Carl-Gustav, Becker, Charlotte, Pettersson, Kim, Scardino, Peter T, Hugosson, Jonas, Lilja, Hans
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474851/
https://www.ncbi.nlm.nih.gov/pubmed/18611265
http://dx.doi.org/10.1186/1741-7015-6-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474851/
https://www.ncbi.nlm.nih.gov/pubmed/18611265
http://dx.doi.org/10.1186/1741-7015-6-19

Ejemplares similares